Divis Laboratories Quarterly Results for Trading Insights
In Mar 2026, Divis Laboratories (DIVISLAB) reported revenue ₹2,986 Cr and net profit ₹751 Cr — revenue +11.8% YoY. For annual financials, live price and key ratios, visit Divis Laboratories share price today.
DIVISLAB Quarterly Results — Revenue, Profit & EPS Highlights
Divis Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Analyse DIVISLAB institutional holdings to track promoter, FII and institutional holdings.
- Revenue of ₹2,986 Cr in Mar 2026 (-5.0% vs Jun 2026, +11.8% vs Mar 2025)
- Net Profit of ₹751 Cr in Mar 2026 (-16.7% vs Jun 2026, +13.4% vs Mar 2025)
- EBITDA of ₹1,089 Cr in Mar 2026 (-17.4% vs Jun 2026)
- Operating Margin of 33.0% in Mar 2026 (-8.0pp vs Jun 2026)
- Earnings Per Share of ₹28.31 in Mar 2026 (-16.6% vs Jun 2026)
Divis Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS
DIVISLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | Jun 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,986 | 3,144 | 2,860 | 2,671 | 2,529 | -5.0% | 11.8% |
| Net Profit (₹ Cr) | 751 | 902 | 689 | 662 | 545 | - | - |
| EBITDA (₹ Cr) | 1,089 | 1,319 | 1,033 | 972 | 848 | - | - |
| EPS (₹) | 28.31 | 33.95 | 25.97 | 24.93 | 20.49 | - | - |
| Operating Margin (%) | 33.0% | 41.0% | 33.0% | 34.0% | 30.0% | - | - |
DIVISLAB Share Price Trend — 1-Year Movement Across Quarterly Results
Divis Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View DIVISLAB 52-week high low for the annual high/low range and current price position.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
DIVISLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Divis Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹441,477.63 Cr | 1837.3 | 15,018 | 2,710 | -5.6% | - | 18.0% | 162.6 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4840.0 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 420.5 |
|
Cipla
Mar 2026 |
₹112,654.03 Cr | 1394.5 | 6,612 | 543 | -9.3% | - | 8.2% | 203.0 |
|
Zydus Life Science
Mar 2026 |
₹112,607.65 Cr | 1160.0 | 7,569 | 1,341 | -4.3% | - | 17.7% | 91.7 |
|
Laurus Labs
Mar 2026 |
₹103,852.21 Cr | 1954.0 | 1,823 | 282 | -10.5% | - | 15.5% | 377.9 |
All amounts in ₹ Crores